compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...

The authors recommend a basal–bolus insulin regimen with glargine or detemir as basal insulin and aspart or lispro as short-acting insulin. Hypokalemia Inadequate potassium replacement and ...

or MDI therapy (bolus insulin aspart and basal NPH insulin) in a multicenter, open-label, randomized, parallel-group, 24-week study. Efficacy was assessed with HbA 1c and eight-point blood glucose ...